终末期心力衰竭与急性心肌梗死所致心源性休克:临时机械循环支持的特征与结局
该单中心研究连续纳入因急性心肌梗死(n=26)和终末期心衰(n=42)导致心源性休克并接受机械循环支持(体外生命支持、Impella或临时心室辅助装置)的患者。测量动脉与静脉血氧含量、二氧化碳分压(PCO2)及氧-血红蛋白亲和力(P50),计算静脉-动脉PCO2差与动-静脉氧含量差比值,并用Gilfix法评估酸碱平衡。结果显示终末期心衰患者射血分数更低、左右心室充盈压及肺动脉压和血管阻力更高、氧输送更低,且并未被升高的血红蛋白P50完全代偿;其静脉-动脉PCO2差相对动-静脉氧含量差更高,提示无氧代谢更重,但代谢性酸中毒和碱缺失反而较急性心梗轻,主要归因于强离子差异。
要点
- 终末期心衰心源性休克患者较急性心梗患者射血分数更低、左右心室充盈压及肺动脉压和血管阻力更高。
- 终末期心衰患者氧输送(DO2)低于急性心梗,且血红蛋白P50升高未能完全代偿。
- 终末期心衰患者静脉-动脉PCO2差与动-静脉氧含量差的比值更高,提示无氧代谢更重。
- 尽管无氧代谢更重,终末期心衰患者代谢性酸中毒和碱缺失反而较急性心梗轻,主要因强离子差异。
- 两组合并机械循环支持相关需干预或手术的并发症情况见原文结果部分。
适用人群与场景
- 因急性心肌梗死(n=26)或终末期心衰(n=42)导致心源性休克并接受机械循环支持(体外生命支持、Impella或临时心室辅助装置)的连续患者,单中心研究。
处置流程与药物剂量
- 机械循环支持方式包括体外生命支持、Impella或临时心室辅助装置,具体选择与剂量未在摘要中给出。
研究设计与关键结果
- 单中心连续病例研究:急性心梗组n=26,终末期心衰组n=42,均接受机械循环支持。
- 终末期心衰组较急性心梗组射血分数更低、左右心室充盈压及肺动脉压和血管阻力更高、氧输送(DO2)更低。
- 终末期心衰组血红蛋白P50升高,但未完全代偿氧输送的降低。
- 终末期心衰组静脉-动脉PCO2差相对动-静脉氧含量差更高,提示无氧代谢更重。
- 终末期心衰组代谢性酸中毒和碱缺失较急性心梗组轻,主要归因于强离子差异。
证据类型、等级与局限
- 证据类型:单中心连续病例研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为终末期心衰所致心源性休克具有与急性心梗不同的表型:充盈压和肺动脉压更高、氧输送更低、无氧代谢更重但代谢性酸中毒更轻。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Mechanical circulatory support (MCS) is increasingly used in cardiogenic shock, but outcomes may differ between patients with acute myocardial infarction (AMI) or end-stage heart failure (ESHF). This study aimed to describe the characteristics of patients with cardiogenic shock due to AMI and ESHF.
METHODS: Single-center study of consecutive patients with cardiogenic shock due to AMI (n = 26) and ESHF (n = 42) who underwent MCS (extracorporeal life support, Impella or temporary ventricular assist devices). Arterial and venous O2 content and CO2 tension (PCO2), O2-hemoglobin affinity (P50) were measured. Veno-arterial difference in PCO2/arterio-venous difference in O2 content ratio was derived. Acid-base balance was characterized by the Gilfix method. MCS-related complications that required intervention or surgery were collected.
RESULTS: Patients with ESHF had lower ejection fraction, higher right and left-sided filling pressures, pulmonary artery pressure and vascular resistance, lower oxygen delivery (DO2) compared with AMI, which was not fully compensated by the increased hemoglobin P50. As a result, patients with ESHF had higher veno-arterial difference in PCO2 relative to arterio-venous difference in O2 content. Despite greater anerobic metabolism, patients with ESHF had less severe metabolic acidosis and base deficit compared with AMI, predominantly due to differences in strong ions.
CONCLUSION: The cardiogenic shock phenotype in ESHF was distinct from AMI, characterized by higher filling and pulmonary artery pressures, lower DO2, greater anaerobic metabolism but less severe metabolic acidosis.
参考来源
- Lim HS, Howell N. Cardiogenic Shock Due to End-Stage Heart Failure and Acute Myocardial Infarction: Characteristics and Outcome of Temporary Mechanical Circulatory Support. Shock. 2018. PMID: 29112104. doi:10.1097/SHK.0000000000001052
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。